SEC Looks Into Stock Trades at Tenet Healthcare

 

November 19, 2002

 

 

Tenet Healthcare Corp. (THC) disclosed that the Securities and Exchange Commission has "opened an informal file" on the hospital company to focus on the huge trading volume in its stock that preceded some company announcements, including statements about certain Medicare payments, Tuesday's Wall Street Journal reported.

 

"We don't know if the SEC intends to launch a formal investigation. We will work closely and cooperate with them," the Santa Barbara, Calif., company said in a lengthy letter to shareholders that was released to the public Monday. Tenet said it met last week with representatives of the SEC's Pacific Regional Office at their request. Diana Tani, assistant regional director in the SEC's Los Angeles office, declined to comment.

 

The shareholder letter also revealed that an independent hospital accreditation organization has begun a review of Tenet's hospitals, and that initial talks began last week with federal auditors who are studying the company's so-called outlier payments, which Medicare pays to defray costs of the most expensive cases.

 

Tenet also disclosed that it repurchased 10 million of its shares last week as part of an effort to restore confidence during a crisis that has tarnished its reputation and clobbered its stock price. Monday, the stock jumped 15% on the buyback news, the biggest bounce since the crisis began three weeks ago.

 

The meltdown was triggered by concerns about the Medicare payments, as well as a federal investigation into allegations that two doctors who practice at a Tenet hospital in Redding, Calif., have performed unnecessary heart surgeries and other invasive procedures. The U.S. Attorney's Office in Sacramento, Calif., which is overseeing the investigation, has said Tenet isn't a target of the probe; the doctors haven't been charged with anything. Last week, a state judge denied a request by the state medical board to stop the doctors from practicing medicine while the investigation continued.

 

Wall Street Journal Staff Reporter Rhonda L. Rundle contributed to this report.

 

Copyright (c) 2002 Dow Jones & Company, Inc.